Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SHP 610

Drug Profile

SHP 610

Alternative Names: HGT-1410; Recombinant human heparan N-sulfatase - Shire; rhHNS - Shire; SHP610

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Shire Pharmaceuticals Group
  • Developer Shire
  • Class Enzymes
  • Mechanism of Action Heparan sulfate sulfatase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mucopolysaccharidosis III
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Mucopolysaccharidosis III

Most Recent Events

  • 30 Aug 2018 Discontinued - Phase-II for Mucopolysaccharidosis III (In children, In infants) in United Kingdom, USA, Netherlands, Argentina, France, Germany, Spain, Italy (Intrathecal)
  • 01 Nov 2016 Shire discontinued a phase II extension trial for Mucopolysaccharidosis III (In children and infants) in Spain due to unmet primary endpoints in a previous phase IIb study (NCT02350816)
  • 01 May 2016 Shire completes a phase IIb trial in Mucopolysaccharidosis III (In infants, In children) in USA, Argentina, France, Germany, Italy, the Netherlands, Spain and the UK (NCT02060526)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top